News & Updates

Get useful insights and updates from us

Latest News

The Edge | 18 April 2024

The Edge | 18 April 2024

Bursa approves UMediC’s transfer to Main Market     KUALA LUMPUR (April 18): Bursa Malaysia Securities Bhd has approved the transfer of UMediC Group Bhd’s listing status from the ACE Market to the Main Market, under the 'health care' sector.  ...

More from news & updates

Capacity expansion, diversification to boost UMediC

Capacity expansion, diversification to boost UMediC

  PETALING JAYA: Robust capacity expansion plans and medical equipment tenders are set to drive UMediC Group Bhd’s (UMC) earnings growth in the near term. Hong Leong Investment Bank Research (HLIB Research) said the medical device maker has relocated its...

New Straits Times | 18 April 2024

New Straits Times | 18 April 2024

KUALA LUMPUR: UMediC (UMC) Group Bhd is well-positioned to expand its manufacturing capacity because of the high demand for its products.  Hong Leong Investment Bank (HLIB) Research noted the company's expansion efforts post-completion of its new facility aim to...

Nanyang Siang Pau | 17 April 2024

Nanyang Siang Pau | 17 April 2024

分析:丰隆投行研究 目标价:0.91令吉   最新进展:   新厂房竣工后,UMediC集团(UMC,0256,创业板)预料可以在今年尾将产能翻倍。   该公司的HydroX预充加湿器系列需求强劲,在此次扩充完成后,UMediC或进一步扩张相关业务。   行家建议:   UMediC集团正为新厂房试营运,以确保生产过程符合标准,之后会逐渐提高产能。   医疗器材和医疗消耗品的竞标市场如今非常火热,而且我们注意到,市场正转向医疗器材租赁模式。我们相信这种模式对...

The Edge | 17 April 2024

The Edge | 17 April 2024

  KUALA LUMPUR (April 17): Hong Leong Investment Bank (HLIB) has maintained its “buy” rating on UMediC Group Bhd (UMC) at 62.5 sen with an unchanged target price (TP) of 91 sen and said UMC's expansion efforts post completion of its new facility aim to double...

UMediC集团 获准转主板

UMediC集团 获准转主板

  (吉隆坡3日讯)UMediC集团(UMC,0256,创业板医疗保健组)获得证券监督委员会批准转至主板上市。   艾芬黄氏投资银行代表UMediC集团董事部宣布,已在周三(3日)收到证监会发出的信函。   证监会根据2007年资金市场服务法令,批准了UMediC集团的上市提议以及将产生的股权结构。   在2021年10月上市的UMediC集团,是在去年底宣布将申请转至主板。该集团旗下有7家子公司。  ...

UMediC获证监会批准转至主板上市

UMediC获证监会批准转至主板上市

(吉隆坡3日讯)UMediC Group Bhd获得大马证券监督委员会(SC)批准,转至大马交易所主板上市。   艾芬黄氏投资银行今日代表UMediC宣布上述消息,指证监会批准了转板上市和由此产生的股权结构。这符合2007年资本市场和服务法令第214(1)条文及上市公司的土著股权要求。   该集团于2022年7月26日在创业板上市。     该集团在截至去年7月杪财年(2023财年)净赚1036万令吉,并录得4543万令吉营业额。  ...

UMediC gets SC’s nod for proposed Main Market transfer

UMediC gets SC’s nod for proposed Main Market transfer

  KUALA LUMPUR (April 3): UMediC Group Bhd has secured approval from the Securities Commission Malaysia (SC) for the proposed transfer to the Main Market of Bursa Malaysia Securities.   Affin Hwang Investment Bank, on behalf of UMediC, announced on Wednesday...

UMedic Receives SC Nod For Main Market Transfer

UMedic Receives SC Nod For Main Market Transfer

  UMedic Group Berhad announced that the Securities Commission had approved the group’s proposed transfer tp the main market of Bursa. The group was incorporated in 2021 as a private limited company under the name of UMediC Group Sdn Bhd and was subsequently...

UMediC to benefit from government’s focus on healthcare

UMediC to benefit from government’s focus on healthcare

  PETALING JAYA: Despite UMediC Group Bhd (UMC) incurring a surge in operating costs, Hong Leong Investment Bank Research (HLIB Research) is upbeat about the medical device maker’s business going forward. The research house said its optimism remains intact,...